tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN

Urogen Pharma (URGN) Revenue

Compare
507 Followers

Urogen Pharma Revenue

Urogen Pharma had a revenue of 24.57M in the quarter ending Dec 31, 2024, with -2.54%. This bring the company's revenue in the last twelve months to 90.40M, Decreased 1.16%. In the fiscal year ending Dec 31, 2024, Urogen Pharma had annual revenue of 90.40M with 9.29% growth.
Revenue (ttm)
90.40M
Revenue Growth
8.98%
P/S Ratio
2.14
Revenue/Employee
$386,316
Employees
234
Market Cap
$193.19M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
90.40M7.68M+9.29%
Dec 31, 2023
82.71M18.36M+28.52%
Dec 31, 2022
64.36M16.32M+33.96%
Dec 31, 2021
48.04M36.24M+307.17%
Dec 31, 2020
11.80M11.78M+65,450.00%
Dec 31, 2019
18.00K-1.11M-98.40%
Dec 31, 2018
1.13M-7.03M-86.17%
Dec 31, 2017
8.16M-9.37M-53.46%
Dec 31, 2016
17.53M+∞%
Dec 31, 2015
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis